Role of biological markers in the clinical outcome of colon cancer.
about
Thymidylate synthetase mRNA levels are increased in liver metastases of colorectal cancer patients resistant to fluoropyrimidine-based chemotherapyMolecular mechanisms of lymphatic metastasis in solid tumors of the gastrointestinal tractDecreased peritherapeutic VEGF expression could be a predictor of responsiveness to first-line FOLFIRI plus bevacizumab in mCRC patientsThymidylate synthase expression and prognosis in colorectal cancer: a meta-analysis of colorectal cancer survival data.[Assessment of angiogenesis expression and its relationship with prognosis of colorectal cancer by conventional and computer-assisted histopathological image analysis].Multimodality imaging to predict response to systemic treatment in patients with advanced colorectal cancer.Have we made progress in pharmacogenomics? The implementation of molecular markers in colon cancer.Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature.Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer.Elevated preoperative carcinoembryonic antigen (CEA) and Ki67 is predictor of decreased survival in IIA stage colon cancer.Predictive value of vascular endothelial growth factor overexpression in early relapse of colorectal cancer patients after curative resection.Correlation between thymidylate synthase protein expression and gene polymorphism with clinicopathological parameters in colorectal carcinoma.The essential role of the in situ immune reaction in human colorectal cancer.Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study.
P2860
Q24795468-34952D98-1AF6-479A-A142-B57FE39EEEFAQ27013620-3C628D79-1533-42F3-972A-0830E1B55890Q27853168-935D1D15-F161-4C6B-861F-35E5263A1AA2Q30570866-1F3B48E8-F626-440B-8E21-93B23B1FDCD7Q33266134-5260E356-8967-4FC7-B923-25E759596B55Q35242758-BC8095AD-898C-41A5-AF5F-01F4AEC56167Q36249234-12600F5E-2C03-4141-9ABF-89277A705022Q36614453-F41F9A8F-1736-4208-947C-E7298E24FD96Q37424106-A2F44B2A-A7D4-4876-82FB-F473A9159F74Q39539087-CC7F232D-8785-45D9-AACA-4DE18DBAF54CQ44344925-5F7F14FD-6C4D-486D-8F4A-74F6711EA8E3Q46160850-0CFBE7A6-1605-4600-A466-9BF7ECEA1CBAQ51964015-9D6FCCE2-F423-405D-BE1C-AE801C06F376Q52595509-4B3800B1-99B6-4695-93B5-D41045CFFDD7
P2860
Role of biological markers in the clinical outcome of colon cancer.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Role of biological markers in the clinical outcome of colon cancer.
@ast
Role of biological markers in the clinical outcome of colon cancer.
@en
type
label
Role of biological markers in the clinical outcome of colon cancer.
@ast
Role of biological markers in the clinical outcome of colon cancer.
@en
prefLabel
Role of biological markers in the clinical outcome of colon cancer.
@ast
Role of biological markers in the clinical outcome of colon cancer.
@en
P2093
P2860
P356
P1476
Role of biological markers in the clinical outcome of colon cancer.
@en
P2093
A M Granato
F De Paola
G L Frassineti
G Oliverio
P2860
P2888
P304
P356
10.1038/SJ.BJC.6600569
P407
P50
P577
2002-10-01T00:00:00Z